New insights into the role of TREM2 in Alzheimer's disease
Alzheimer's disease (AD) is the leading cause of dementia. The two histopathological
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
Microglia in Alzheimer disease: well-known targets and new opportunities
AL Hemonnot, J Hua, L Ulmann… - Frontiers in aging …, 2019 - frontiersin.org
Microglia are the resident macrophages of the central nervous system. They play key roles
in brain development, and physiology during life and aging. Equipped with a variety of …
in brain development, and physiology during life and aging. Equipped with a variety of …
Global prevalence of young-onset dementia: a systematic review and meta-analysis
S Hendriks, K Peetoom, C Bakker… - JAMA …, 2021 - jamanetwork.com
Importance Reliable prevalence estimates are lacking for young-onset dementia (YOD), in
which symptoms of dementia start before the age of 65 years. Such estimates are needed for …
which symptoms of dementia start before the age of 65 years. Such estimates are needed for …
A clinicopathological approach to the diagnosis of dementia
FM Elahi, BL Miller - Nature Reviews Neurology, 2017 - nature.com
The most definitive classification systems for dementia are based on the underlying
pathology which, in turn, is categorized largely according to the observed accumulation of …
pathology which, in turn, is categorized largely according to the observed accumulation of …
Early-onset Alzheimer disease and its variants
MF Mendez - CONTINUUM: Lifelong Learning in Neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW Early-onset Alzheimer disease (AD) is defined as having an age of
onset younger than 65 years. While early-onset AD is often overshadowed by the more …
onset younger than 65 years. While early-onset AD is often overshadowed by the more …
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes
ITS Coyle-Gilchrist, KM Dick, K Patterson… - Neurology, 2016 - AAN Enterprises
Objectives: To estimate the lifetime risk, prevalence, incidence, and mortality of the principal
clinical syndromes associated with frontotemporal lobar degeneration (FTLD) using revised …
clinical syndromes associated with frontotemporal lobar degeneration (FTLD) using revised …
Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper
L Hill, T Prager Geller, R Baruah… - European journal of …, 2020 - Wiley Online Library
The Heart Failure Association of the European Society of Cardiology has published a
previous position paper and various guidelines over the past decade recognizing the value …
previous position paper and various guidelines over the past decade recognizing the value …
The epidemiology of frontotemporal dementia
CU Onyike, J Diehl-Schmid - International review of psychiatry, 2013 - Taylor & Francis
Frontotemporal dementia, a heterogeneous neurodegenerative disorder, is a common
cause of young onset dementia (ie dementia developing in midlife or earlier). The estimated …
cause of young onset dementia (ie dementia developing in midlife or earlier). The estimated …
The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies
SAV Jones, JT O'brien - Psychological medicine, 2014 - cambridge.org
BackgroundDementia with Lewy bodies (DLB) is increasingly recognized as a common
cause of dementia in older people. However, its true frequency remains unclear, with …
cause of dementia in older people. However, its true frequency remains unclear, with …
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease
B Fonseca-Santos, MPD Gremião… - International Journal of …, 2015 - Taylor & Francis
Alzheimer's disease is a neurological disorder that results in cognitive and behavioral
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …